×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Teledyne Technologies Acquires Varex Imaging for $1.1 Billion in Cash

  • August 10, 2026

Teledyne Technologies - Varex Imaging Merger

Teledyne Technologies Incorporated (TDY) entered a merger agreement on August 10, 2026, to acquire Varex Imaging Corporation (VREX) in a deal valued at $1.1 billion.

Deal Structure:

Varex stockholders will receive $18.9 per share payable in cash, representing a premium of 52.3% from the stock’s last close.

Company Profile:

Varex Imaging is a U.S.-based manufacturer of X-ray imaging components and systems for medical and industrial applications. Its products include X-ray tubes, digital detectors, imaging software, and other components used in diagnostic imaging, security, and industrial inspection.

Teledyne Technologies is a U.S.-based technology company that develops digital imaging products, instrumentation, aerospace and defense electronics, and engineered systems. Its products serve industrial, aerospace, defense, environmental, and scientific applications.

Deal Details and Timeline:

The deal is anticipated to be completed in early 2027.

Varex received financial advice from Evercore, with Orrick, Herrington & Sutcliffe serving as its legal advisor. Teledyne received legal counsel from Latham & Watkins and McGuireWoods.

Teledyne Technologies is paying 9.25 times Varex’s EBITDA.

Deal Metrics:

For a comprehensive understanding of this merger and acquisition transaction’s details, please refer to the Deal Metrics page at the following link:

Deal Metrics for the acquisition of Varex Imaging Corporation (VREX) by Teledyne Technologies Incorporated (TDY)

The Deal Metrics page for each merger or acquisition includes:

  • A spread history chart of the merger from announcement through eventual completion or failure.
  • A timeline of every event as the merger progresses, including the expiration of the HSR period, various regulatory approvals, shareholder votes, etc.
  • News and SEC filings related to the deal.
  • A history of deal updates.
  • And a lot more intricate details.

Disclaimer: Please perform your own due diligence before buying or selling any securities mentioned in this article. We cannot guarantee the completeness or accuracy of the content or data provided in this article.

Editor’s Note: Baranjot Kaur contributed to this article